Top Glove Corporation Bhd returned to the black in the financial year ended Aug 31 2025 (FY2025), posting a net profit attributable to shareholders of RM109.1 million compared with a RM64.9 million loss a year earlier, as a 55% jump in sales volume lifted utilisation rates and widened margins.

Revenue rose 39% year-on-year (YoY) to RM3.49 billion, while basic earnings per share swung to 1.36 sen from a loss of 0.81 sen. The board declared a final dividend of 0.48 sen per share—its first payout since FY2022—amounting to RM38.5 million and payable on Dec 15 2025.

Group profit before tax recovered to RM154.4 million from a RM31.3 million loss in FY2024, supported by operating profit of RM89.0 million (FY2024: RM205.0 million loss). By geography, Malaysia remained the main contributor with RM3.22 billion in revenue and RM177.3 million pretax profit, offsetting losses in Thailand (pretax loss RM12.6 million) and Vietnam (pretax loss RM12.4 million).

The turnaround was driven by higher glove demand, which boosted running capacity utilisation to about 75% in August 2025, resulting in operating leverage and lower unit costs. Declines in raw-material prices—natural latex concentrate down 14% and nitrile latex down 10% quarter-on-quarter—also cushioned the impact of a weaker U.S. dollar.

Issuance of a RM800 million five-year senior sukuk in February funded the RM1.18 billion redemption of an existing perpetual sukuk, trimming annual distribution costs. At end-FY2025, net assets stood at RM4.78 billion (FY2024: RM5.84 billion) and cash and bank balances at RM298.4 million.

Looking ahead, the group plans to expand its U.S. market share in FY2026 to mitigate fierce competition in other regions. Management said ongoing quality and cost-optimisation initiatives, together with new product launches such as chemotherapy-tested nitrile gloves and biodegradable industrial gloves, would support sustainable growth.

Managing Director Lim Cheong Guan noted that disciplined execution of cost-efficiency measures positioned the company to benefit from the demand recovery, while Executive Chairman Tan Sri Dr Lim Wee Chai said Top Glove is “better prepared to face international competition” after improving its cost structure and expects to build on FY2025’s momentum to regain market leadership.

The company remains upbeat on long-term glove demand across healthcare, industrial and food-and-beverage sectors, but cautioned that labour shortages, rising costs and currency fluctuations will require continued operational discipline.